Description

Copegus Coated Tablets 200 mg. №168

Ingredients:

Each coated tablet contains 200 mg of Ribavirin.

Dosage:

The recommended dosage of Copegus is individualized based on weight and medical condition. Consult your healthcare provider for the appropriate dosage.

Indications:

Copegus is indicated for the treatment of chronic hepatitis C in combination with other antiviral medications.

Contraindications:

Do not use Copegus if you are pregnant, have severe kidney disease, or have a history of severe heart disease.

Directions:

Take Copegus exactly as prescribed by your healthcare provider. Do not alter the dosage or stop taking the medication without consulting your doctor.

Scientific Evidence:

Ribavirin, the active ingredient in Copegus, has been extensively studied for its efficacy in treating chronic hepatitis C. Clinical trials have demonstrated that Ribavirin, when used in combination with other antiviral agents, can significantly improve viral clearance rates and reduce liver inflammation.

Research published in the Journal of Viral Hepatitis has shown that Ribavirin-based regimens are effective in achieving sustained virologic response in patients with chronic hepatitis C, leading to long-term remission of the disease.

Additional Information:

• Storage: Store Copegus at room temperature away from moisture and heat.
• Side Effects: Common side effects of Copegus include fatigue, nausea, and anemia. Consult your doctor if you experience severe side effects.